Skip to main content
. 2020 Sep 23;22:520–529. doi: 10.1016/j.omtn.2020.09.017

Figure 6.

Figure 6

The Expression of IL-17a Was Obviously Upregulated in the Plasma, Peripheral Blood Monocytes, and Sputum of COPD Patients in the Exacerbation-Month12 Group

(A) The expression of IL-17a was enhanced in the plasma of COPD patients in the exacerbation-month12 group. (B) The expression of IL-17a was enhanced in the peripheral blood monocytes of COPD patients in the exacerbation-month12 group. (C) The expression of IL-17a was enhanced in the sputum of COPD patients in the exacerbation-month12 group.